761results about How to "Quick cure" patented technology

Medical devices, methods and systems for treating tissue are provided. An exemplary system comprises a fluid from a fluid from a fluid source at a fluid flow rate, a surgical device which provides power and the fluid to the tissue and a control mechanism which changes a fluid flow rate provided from the surgical device and changes a power level provided from the surgical device. The fluid flow rate changes between at least two-zero flow rates and the power level changes between at least two non-zero levels. An exemplary method comprises providing a fluid from a fluid source at a fluid flow rate, providing a surgical device which provides power and the fluid to the tissue, and changing the fluid flow rate of fluid provided from the surgical device with a change in power level provided from the surgical device.

A method and apparatus for treatment of skin or other tissue, using a source of thermal, electromagnetic radiation, electrical current, ultrasonic, mechanical or other type of energy, to cause minimally-invasive thermally-mediated effects in skin or other tissue which stimulates a wound-healing response, in conjunction with topical agents or other wound healing compositions, for application on the skin or other tissue which accelerate collagenesis, such as in response to wound healing. The dosage and time period of application of the compositions are adjusted to prevent external or surface tissue damage.

Ablation catheter for setting a lesion, which catheter contains an ablation element that can be slid out of a catheter sleeve and has a looped section which, when said element is slid out, will self-expand into an automatically or manually imposed pre-specified shape corresponding to the actual shape of the area of tissue requiring to be ablated.

The invention relates to a Chinese medicine plaster for treating diseases in muscles and bones, in particular to a plaster for promoting muscles and bones, and preparation and application thereof. The plaster is prepared by mixing pastes and powders; wherein the raw materials of the pastes by weight comprise: 25-60g of clematis root, 25-60g of heracleum, 25-60g of incised notopterygium rhizome, 25-60g of erycibe obtusifolia, 25-60g of garden balsam stem, 25-60g of gentiana macrophylla, 25-60g of prepared common monkshood daughter root, 25-60g of dried ginger, 25-60g of cinnamon, 25-60g of harlequin glorybower leaf and twig, 25-60g of rhizoma corydalis, 25-60g of ligusticum wallichii, 25-60g of frankincense, 25-60g of cowherb seed, 25-60g of lingzhi mushroom, 25-60g of gastrodia elata and 25-60g of astragalus, 25-60g of one or more of honeycomb, radix aconiti brachypodi and nux vomica, 0.1-3kg of minium and 0.5-5kg of vegetable oil; and the raw materials of the powders by weight comprise: 15-45g of clematis root, 15-45g of heracleum, 15-45g of incised notopterygium rhizome, 15-45g of phellodendron amurense, 15-45g of dragon's blood, 15-45g of gastrodia elata, 15-45g of nux vomica, 15-45g of rhizoma corydalis, 15-45g of borneol, 15-45g of harlequin glorybower leaf and twig and 15-45g of common monkshood mother root. The plaster for promoting muscles and bones has balanced effect, high medicine utilization ratio and good treatment effect.

The invention provides, inter alia, a method for producing granules from a powder, characterized in that a low compaction force is applied to the powder to produce a compacted mass comprising a mixture of fine particles and granules and separating fine particles from the granules by entraining the fine particles in a gas stream. Also provided are apparatus for use in the process and tablets formed by compression of the resultant granules.

Certain embodiments provide methods and systems by which a predictive modeling provider may provide a client with predictive healthcare analysis. The predictive healthcare analysis may be used to assess whether a beneficiary is likely to develop conditions requiring healthcare. If such conditions are identified, intervention plans are developed and implemented to address the conditions and reduce healthcare costs. Certain embodiments provide method and systems by which an integrated benefits management organization may manage a client's healthcare program. A claim audit may be performed on healthcare claims of the client's beneficiaries. A claim repricing process may be used to discount the healthcare claims of the client's beneficiaries. In at least certain embodiments, the predictive modeling provider or integrated benefits management organization are motivated to maximize the reduction in the client's healthcare costs.

Methods of characterizing and identifying microorganisms within a community of microorganisms are described. The methods include amplifying variable regions of the cpn60 gene of samples taken from the microbial community. Primers designed from the analysis of phylogenetic comparisons of nucleotide sequences of the variable regions of the cpn60 gene are also disclosed.

The present invention provides method and apparatus for treating tissue in a region at depth by applying optical radiation thereto of a wavelength able to reach the depth of the region and of a selected relatively low power for a duration sufficient for the radiation to effect the desired treatment while concurrently cooling tissue above the selected region to protect such tissue. Treatment may be enhanced by applying mechanical, acoustic or electrical stimulation to the region.

The invention concerns an expandable intersomatic cage (1) intended to be implanted between a first and second vertebral bodies of a patient, comprising:a cage body (2), comprising a bearing surface (6A) intended to be positioned so as to bear against the first vertebral body (4),an expansion cap (3) mounted on the cage body (2) so as to be able to pivot relative to the bearing surface (6A), said expansion cap (3) comprising an element (3A) for bearing against the second vertebral body (5),a means (16) for controlling the inclination of the expansion cap (3).said cage (1) being characterized in that the body (2) comprises at least one fastening orifice (41) forming an oblique well (42) capable of receiving and guiding from the outside of said cage (1) a means for fastening the cage (1) to the first and / or to the second vertebral body.Surgical implants.

Disclosed are a system, device and process for monitoring physical and physiological features of livestock through a unique monitoring system and device. Basic and Smart tags are placed on livestock to monitor, among other things, temperature, movement, location, posture, pulse rate, and other physical and physiological features. Information is relayed from Basic tags, in one embodiment, to Smart tags that requests the information and receives the information from the basic tags. Smart tags send information to a mobile unit controller and / or home base so that requested information is sent to an end user that monitors the livestock for signs of illness. Potentially ill animals are segregated from the herd for further evaluation and minimization of exposure risk to the rest of the herd. This early detection system saves livestock and ensures a healthier herd for livestock farmers.

A medical resuscitation system includes an external physiological stimulator system module for resuscitating a patient and an external communication system module. The external physiological stimulator and communication system modules are removeably coupled together. The external communication system module can flow a signal between it and an electronic patient information module carried by a patient. The external physiological stimulator system module can resuscitate the patient in response to this signal.

In an electonic key associated with a device for skin treatment there is a housing and an integrated circuit, the integrated circuit is positioned within the housing, wherein the device for treating human tissue comprises a surgical instrument having a gas conduit terminating in a plasma exit nozzle, and an electrode associated with the conduit, and a radio frequency power generator coupled to the instrument electrode and arranged to deliver radio frequency power to the electrode in single or series of treatment pulses for creating a plasma from gas fed through the conduit, the pulses having durations in the range of from 2 ms to 100 ms.

The present invention is directed to a novel progression of topical and oral administration or use of lactoferrin or lactoferrin and other biological ingredients to prevent and treat dermatological conditions or disorders in humans. More specifically, the present invention is directed to the administration of lactoferrin in a topical material such as an ointment or cream to the skin of humans and also including a oral administration, together the topical and oral administration has a synergetic effect in the treatment of the skin. The progression of medicaments of the present invention are: 1) lactoferrin; 2) lactoferrin and conjugated linoleic acids; 3) lactoferrin, a plant or animal derived lipid and oblepicha; 4) lactoferrin, a plant or animal derived lipid, oblepicha, and an omega fatty acid; and 5) lactoferrin, a plant or animal derived lipid, oblepicha, an omega fatty acid and a whey protein.

Apparatus for helmeting with carotid collars works in conjunction with a transcranial Doppler, phased array photoacoustic device to transmit a first energy to a region of interest at an internal site of a subject to produce an image and blood flow velocities of a region of interest by outputting an optical excitation energy to said region of interest and heating said region, causing a transient thermoelastic expansion and produce a wideband ultrasonic emission. Systems integrate and register the signals for use in, for example, acute stroke care.

A magnetic stimulation device and methods use a plurality of magnetic field generating devices, allowing for faster treatment of a patient and for treatment of large areas of the body. The shape of the generated magnetic field may be adjusted by an operator. The magnetic stimulation device is able to provide a plurality of various treatments at the same time.

The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid and durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is particularly useful, for example, for treatment of microbes such as for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system. The invention also useful for the treatment of pathogenic bacterial infections in subjects receiving a treatment for a disease or condition, such as a transplant or a treatment for cancer, a viral infection or an autoimmune disease.

A dielectric barrier discharge plasma generator includes a dielectric chamber. The chamber contains or incorporates a solid surface that is to be treated with non-thermal plasma. The dielectric chamber can be substantially sealed and confine an atmosphere therein. An atmosphere control system is provided for controlling the atmosphere within the chamber. At least one or two electrodes are located outside of the dielectric chamber. When actuated by an appropriate source of plasma generating electrical power the electrodes cause the generation of a solid surface modifying non-thermal plasma in a plasma zone within the dielectric chamber. A transport system is provided for moving the electrode and the dielectric chamber relative to one another. A plasma zone is confined within the dielectric chamber adjacent to the electrodes, and remains substantially stationary relative to the electrodes. The dielectric chamber carries the solid surface through the plasma zone. The solid surface remains substantially stationary relative to the dielectric chamber.

The invention discloses an in-vivo wireless communication device based on a vascular stent and a wireless communication system. The in-vivo wireless communication device comprises the vascular stent and a trigger circuit mounted on the vascular stent, the trigger circuit is used for acquiring health condition data related to vascular diseases and / or providing in-vivo therapy related to the vascular diseases, an output of the trigger circuit is fed to the vascular stent, the vascular stent serves as an antenna to transmit wireless signals outwards, and the vascular stent further serves as the antenna to receive wireless signals in vitro and transmit the wireless signals to the trigger circuit. A special antenna structure does not need to be arranged in a blood vessel, the in-vivo wireless communication device is small in size, and the blood vessel can be monitored and treated in real time at low cost.

Methods and apparatus are disclosed for treating physiological problems, and for providing rapid, efficacious transdermal treatment, for example, of muscle sprains, erectile dysfunction, or baldness, without requiring the use of needles or other invasive interventions. A topical therapeutic agent and ultrasound energy are applied to a tissue surface, e.g., the skin, such that the ultrasound enhances transdermal penetration of the agent. The invention is especially useful in localized delivery of a controlled dosage of a therapeutic agent to the small blood vessels and capillaries beneath the skin's surface.

The invention discloses gRNA for knockout of a wild type T cell TCR [beta] strand and a method. The sequence of the gRNA is as shown in SEQ ID NO: 1, by utilizing a CRISPR / Cas9 technology, the gRNA and CRISPR / Cas9 jointly infect a T cell, the wild type T cell TCR [beta] strand is knocked out, and the T cell lacking the wild type TCR [beta] strand is constructed and used for CAR-T or TCR-T cellular immunotherapy. According to the gRNA for knockout of the wild type T cell TCR [beta] strand and the method, the knockout efficiency is high, the preparation method is relatively simple and easy, and T cells lacking wild type TCR [beta] strands can be provided for clinic rapidly and efficiently.

Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (Cmax) and slightly delaying the peak such as to avoid activating the dopaminergic and adrenergic receptors, while achieving sufficient active binding to the serotonin receptors to provide relief from migraine symptoms within a timeframe that permits rapid resolution of migraine symptoms. Inhaler devices suitable for the methods are disclosed. Kits for practicing the methods of invention are disclosed.

Disclosed herein are devices and methods for guiding a surgical instrument for resecting a portion of a humerus of a patient. The surgical instrument is a patient-specific cutting guide having a base portion having a contact surface shaped to substantially match an outer surface of a neck portion of the humerus. The guide includes at least one proximal stabilization member extending medially from the base portion and having a contact surface shaped to substantially match an outer surface of a head portion of the humerus. The guide further includes at least one distal stabilization member extending distally from the base portion and having a contact surface shaped to substantially match an outer surface of a shaft portion of the humerus. The base portion includes a guide slot for guiding the surgical instrument.

Methods for treating malaria are provided, the treatment comprising the step of removing malaria-infected red blood cells from the patient s blood. Blood is drawn from the patient s circulatory system and circulated through a blood purification device that selectively eliminates the infected red blood cells from all other blood s components and replaces the cleansed blood back into the patient s circulatory system. A blood purification device, which is useful to perform the therapeutic methods of the invention, is also provided. The device leverages the magnetic properties of the hemozoin contained within the infected red blood cells and comprises one or more separation chambers (4) though which blood flows through a high-gradient magnetic field generated by an array of wires (5) separated from the chambers and not in contact with the patient blood. The magnetic field gradient acting on the cells magnetic properties displaces the infected and non-infected red blood cells on different layers of the blood flow across the chamber height. The blood flow is split into separated streams and blood streams containing infected cells are filtrated thereby trapping infected cells. Blood containing non-infected red blood cells is circulated back to the patient. The device application is not limited to the treatment of malaria and includes other blood related diseases that affect the magnetic properties of a patient's red blood cells.

A method of treating or preventing skin yeast infections, such as cutaneous candidiasis, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to a skin yeast infection, optionally with at least one of an additional anti-fungal agent or a skin care additive, and allowing the polymerizable monomer composition to polymerize to form a polymer film over the area of skin.

Disclosed herein are devices and methods for guiding a surgical instrument for resecting a portion of a humerus of a patient. The surgical instrument is a patient-specific cutting guide having a base portion having a contact surface shaped to substantially match an outer surface of a neck portion of the humerus. The guide includes at least one proximal stabilization member extending medially from the base portion and having a contact surface shaped to substantially match an outer surface of a head portion of the humerus. The guide further includes at least one distal stabilization member extending distally from the base portion and having a contact surface shaped to substantially match an outer surface of a shaft portion of the humerus. The base portion includes a guide slot for guiding the surgical instrument.

The invention relates to a patient ventilation or breathing device and components therefore for use in all forms of respiratory apparatus ventilation systems including invasive and non-invasive ventilation, positive airway pressure therapy, Continuous Positive Airway Pressure (CPAP), and particularly Bi-Level therapy and treatment for sleep disordered breathing (SDB) conditions such as Obstructive Sleep Apnea (OSA), and for various other respiratory disorders and diseases. The invention particularly relates to a blower, to a blade, to a gasket, to a cable, to an impeller, to a gas inlet and inlet member, to an improved air path or fluid flow path and components thereof, and / or to a modular ventilation or breathing device as referred to above and particularly incorporating one or more of the other aspects of the invention.